Leidos mobilizes supply chain to scale production of thousands of U.S. cruise missiles

Leidos convened missile-component suppliers to scale production of its Low-Cost Containerized Missile (LCCM) and AGM-190A Havoc Spear, supporting a Department of War framework agreement for an initial 3,000 LCCM weapons. LCCM test-and-evaluation deliveries are expected in 2027, with full-rate production anticipated in 2028–2029; initial Havoc Spear deliveries to Air Force Special Operations Command are underway. Leidos also received a summer 2026 U.S. Special Operations Command award for 45 Havoc Spear missiles, with deliveries expected to begin in fall 2027; supplier work will span 14 states.

Analysis

LDOS’s upside is chiefly an execution-and-backlog option, not yet evidence of a near-term earnings step-up. The 2027 test deliveries and 2028–29 LCCM ramp leave a long gap between today’s capacity plans and meaningful production revenue. The headline quantity should not be treated as funded backlog until contract structure, appropriations, pricing, and delivery obligations are confirmed. Supplier coordination may reduce integration delays, but accelerating output also exposes the program to shared bottlenecks in propulsion, components, labor, and qualification; capacity commitments can raise cost before customer acceptance converts them into revenue. Any margin benefit is therefore conditional on contract economics and yield during scale-up.

Near term, the announcement may support defense sentiment, but it provides no unit economics or incremental guidance with which to underwrite a material valuation revision. Over 1–3 months, the useful catalysts are funded awards, backlog disclosure, and supplier/production milestones. Over 6–18 months, test results and the ability to qualify production—not stated capacity—will determine whether the program becomes durable growth. The contrarian risk is that investors capitalize aspirational volume too early; the counterpoint is that repeated procurement and successful qualification could establish a broader low-cost strike franchise. Thesis weakens if LCCM test or production milestones slip, funding fails to follow the framework, or LDOS indicates unfavorable program economics.

Key Decisions for Investors

• No event-driven chase in LDOS on this release alone: the article adds production intent, but not disclosed contract value, incremental funded backlog, or margin guidance.
• Put LDOS on a catalyst watch for the next earnings release and procurement updates. Upgrade the thesis only after verifying funded LCCM obligations, contract type/pricing, expected revenue timing, and any change to company guidance.
• Track supplier capacity and qualification milestones, particularly propulsion and component availability. Delays or cost growth would put the production ramp at risk even if demand remains strong.
• Treat a long LDOS as a conditional medium-term idea after evidence of funded orders and on-schedule testing; reassess if the 2027 test-delivery milestone slips or the 2028–29 production outlook is reduced.